ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial

Status unconfirmed

Conditions studied: Oral Mucositis, Nausea, Vomiting, Diarrhea

In brief

RATIONALE: Polymerized (cross-linked) sucralfate malate paste (ProThelial) may be an effective single therapy approach for the management of chemoradiation mucositis, treating and preventing its occurrence in the oral cavity, esophagus, stomach, small and large intestine. PURPOSE: This observational multi-phase trial is studying how well polymerized (cross-linked) sucralfate malate paste (ProThelial) works to prevent and treat mucositis in adult patients who are to receive or have received chemo/radiation therapy that have caused or is anticipated to cause mucositis in the oral cavity, esophagus, stomach, small or large intestine. The Phase IV study addresses prevention and treatment in the oral cavity. The Phase I study addresses prevention and treatment in the esophagus, stomach, small and large intestine.

Key facts

Study ID

NCT02016807

Run by

Ashley Downs Bioscience

People needed

180

Starts

2013-01-01

Expected to finish

2015-01-01

Last updated by the study team

2013-12-20

Who can join

Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years and older
• Informed consent
• Patients receiving cancer therapy with agents likely to cause mucositis
• Patients who have developed mucositis from chemo/and or radiation
• Patients to receive these that cause nausea, vomiting
• Patients to receive these that cause diarrhea
• Patients with Head \& Neck cancer to receive chemo/radiation and G-Tube
• Patients to undergo Hematopoietic Stem Cell Transplantation

You may not qualify if…

• Absence of consent
• Unable or unwilling to complete the self assessment questionnaire.
• Use of any mouthwash out of study
• Simultaneous treatment by an agent for prevention/treatment of mucositis
• Patients with baseline creatinine level greater than or equal to 3 or any patient with renal insufficiency requiring dialysis
• Have known allergies or intolerance to ProThelial or its ingredients (sucralfate)

Where it is running

• Translational Medicine Research Center — Foster, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.